Active Ingredient: ESOMEPRAZOLE MAGNESIUM
Proprietary Name: ESOMEPRAZOLE MAGNESIUM
Dosage Form; Route of Administration: FOR SUSPENSION, DELAYED RELEASE; ORAL
Strength: EQ 20MG BASE/PACKET
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211751
Product Number: 001
Approval Date: Mar 23, 2020
Applicant Holder Full Name: CIPLA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
